First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Ahead of the 2026 Academy Awards, take a look at the titles that have been adapted into some of the recognized films, and books that perfectly accompany others Michelle Mehrtens | Arts and Culture ...

The MarketWatch News Department was not involved in the creation of this content. -- Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated ...

Manga Mavericks LLC, a new manga publisher serving North America, has announced a distribution deal with Pathway Book Service, a specialized distributor and logistics provider. Pathway will manage ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...

Add Yahoo as a preferred source to see more of our stories on Google. Icelandic composer and double bassist Bára Gísladóttir - Rui Camilo As the winter evenings draw in, music becomes a solace as well ...

Young students at Montgomery Public Schools are getting their choice of free books through a partnership with the Equal Justice Initiative. As a result of the partnership, elementary school kids in ...

SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...

A small worn pocket journal with a fading image of a black sunflower is where this poet's thoughts, soon to be poems, alight like butterflies that demand a closer look. It's where spoken-word artist ...